Spina bifida research resource: Study design and participant characteristics

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 82, Issue 10, 2008, Pages 684-691

  Mitchell, Laura E ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Birth defect; Epidemiology; Genetic; Myelomeningocele; Neural tube; Spina bifida

Indexed keywords

ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; EMBRYO CELL; FEMALE; HUMAN; HUMAN GENETICS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MENINGOMYELOCELE; PRIORITY JOURNAL; SPINA BIFIDA; THORACIC SPINE;

FAMILY; FEMALE; GENOME, HUMAN; HEALTH RESOURCES; HUMANS; MALE; MENINGOMYELOCELE; RESEARCH DESIGN; SPINAL DYSRAPHISM;

EID: 55449109011     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20465     Document Type: Article

References (39)

1. Boyles AL, Billups AV, Deak KL, et al. 2006. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environmental Health Perspect 114:1547-1552.
2. Brown KS, Cook M, Hoess K, et al. 2004. Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Res A Clin Mol Teratol 70:101-106.
3. Carter CO. 1969. Genetics of common disorders. Br Med J 25:52-57.
4. Christianson A, Howson CP, Modell B. 2006. March of Dimes Global Report on Birth Defects. White Plains, NY: March of Dimes Birth Defect Foundation. http://www.marchofdimes.com/MOD-Report-PF.pdf.
5. Doolin MT, Barbaux S, McDonnell M, et al. 2002. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71:1222-1226.
6. Frecker MF, Fraser FC, Heneghan WD. 1988. Are "upper" and "lower" neural tube defects aetiologically different? J Med Genet 25:503-504.
7. Glynn RJ, Rosner B. 2004. Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol 57:113-122.
8. Hall JG, Friedman JM, Kenna BA, et al. 1988. Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet 43:827-837.
9. Jensen LE, Barbaux S, Hoess K, et al. 2004a. The human T locus and spina bifida risk. Hum Genet 115:475-482.
10. Jensen LE, Hoess K, Mitchell LE, et al. 2006. Loss of function polymorphisms in NAT1 protect against spina bifida. Hum Genet 120:52-57.
11. Jensen LE, Hoess K, Whitehead AS, et al. 2005. The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida. Birth Defects Res A Clin Mol Teratol 73:512-516.
12. Jensen LE, Wall AM, Cook M, et al. 2004b. A common ABCC2 promoter polymorphism is not a determinant of the risk of spina bifida. Birth Defects Res A Clin Mol Teratol 70:396-399.
13. Kallen B, Robert E, Harris J. 1998. Associated malformations in infants and fetuses with upper or lower neural tube defects. Teratology 57:56-63.
14. Khoury MJ, Erickson JD, James LM. 1982a. Etiologic heterogeneity of neural tube defects. II. Clues from family studies. Am J Hum Genet 34:980-987.
15. Khoury MJ, Erickson JD, James LM. 1982b. Etiologic heterogeneity of neural tube defects: clues from epidemiology. Am J Epidemiol 115:538-548.
16. King TM, Au KS, Kirkpatrick TJ, et al. 2007. The impact of BRCA1 on spina bifida meningomyelocele lesions. Ann Hum Genet 71:719-728.
17. Lemire RJ. 1988. Neural tube defects. JAMA 259:558-562.
18. Lynch SA. 2005. Non-multifactorial neural tube defects. Am J Med Genet 135:69-76.
19. McCarroll SA, Altshuler DM. 2007. Copy-number variation and association studies of human disease. Nat Genet 39:S37-S42.
20. Mitchell LE. 1997. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium. Am J Hum Genet 60:1006-1007.
21. Mitchell LE. 2005. Epidemiology of neural tube defects. Am J Med Genet 135C:88-94.
22. Mitchell LE, Adzick NS, Melchionne J, et al. 2004. Spina Bifida. Lancet 364:1885-1895.
23. Mitchell LE, Weinberg CR. 2005. Evaluation of offspring and maternal genetic effects on disease risk using a family-based approach: the "pent" design. Am J Epidemiol 162:676-685.
24. Moore CA. 2006. Classification of Neural Tube Defects. In: Wyszynski DF, editor. Neural Tube Defects From Origin to Treatment. New York: Oxford University Press. p 66-75.
25. Moretti ME, Bar-Oz B, Fried S, et al. 2005. Maternal Hyperthermia and the Risk for Neural Tube Defects in Offspring. Epidemiology 16:216-219.
26. Newton-Cheh C, Hirschhorn JN. 2005. Genetic association studies of complex traits: design and analysis issues. Mutation Res 573:54-69.
27. Pitkin RM. 2007. Folate and neural tube defects. Am J Clin Nutr 85:S285-S288.
28. Posey DL, Khoury MJ, Mulinare J, et al. 1996. Is mutated MTHFR a risk factor for neural tube defects. Lancet 347:686-689.
29. Rogers NL, Cole SA, Lan HC, et al. 2007. New saliva DNA collection method compared to buccal cell collection techniques for epidemiological studies. Am J Hum Biol 19:319-326.
30. Seaver LH, Stevenson RE. 2006. Syndromes with Neural Tube Defects. In: Wyszynski DF, editor. Neural Tube Defects From Origin to Treatment. New York: Oxford University Press. p 76-83.
31. Stoll C, Alembik Y, Dott B. 2007. Associated malformations in cases with neural tube defects. Genet Counsel 18:209-215.
32. Toriello HV, Higgins JV. 1985. Possible causal heterogeneity in spina bifida cystica. Am J Med Genet 21:13-20.
33. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
34. Volcik KA, Shaw GM, Lammer EJ, et al. 2003. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res A Clin Mol Teratol 67:154-157.
35. Waller DK, Shaw GM, Rasmussen SA, et al. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Ped Adolesc Med 161:745-750.
36. Weinberg CR. 2003. Studying parents and grandparents to assess genetic contributions to early-onset disease. Am J Hum Genet 72:438-447.
37. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62:969-978.
38. Whitehead AS, Gallagher P, Mills JL, et al. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Quart J Med 88:763-766.
39. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Reports 116 Suppl 1:32-40.